Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michiel van de Sande

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Anticancer Research|September 4, 2020
Clinical Outcome of Surgically Treated Leiomyosarcoma of the Extremities: A Retrospective OverviewAnnelies VAN Beeck, Michiel VAN DE Sande, Veroniek VAN Praag, et al.
Journal of Clinical Pharmacology|October 12, 2020
Population Pharmacokinetic Analysis of Pexidartinib in Healthy Subjects and Patients With Tenosynovial Giant Cell Tumor or Other Solid TumorsOphelia Yin, Andrew J Wagner, Jia Kang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 15, 2018
Time dependent dynamics of wound complications after preoperative radiotherapy in Extremity Soft Tissue SarcomasJules Lansu, Jan Groenewegen, Frits van Coevorden, et al.
Sarcoma|December 9, 2014
Can orthopedic oncologists predict functional outcome in patients with sarcoma after limb salvage surgery in the lower limb? A nationwide studySjoerd Kolk, Kevin Cox, Vivian Weerdesteyn, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 18, 2021
Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centresMaria Anna Smolle, Michiel van de Sande, Andrew Hayes, et al.
Journal of Surgical Oncology|February 1, 2020
Incidence, treatment and outcome of abdominal metastases in extremity soft tissue sarcoma: Results from a multi-centre studyMaria A Smolle, Angelika Schaffler, Andreas Leithner, et al.
Clinical Sarcoma Research|December 9, 2020
Seeking international consensus on approaches to primary tumour treatment in Ewing sarcomaCraig Gerrand, Jessica Bate, Beatrice Seddon, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 1, 2026
Mixed-Methods to Define Meaningful Change using Exit Interviewand Clinical Trial Data in Patients with Tenosynovial Giant Cell Tumor (TGCT)Heather L Gelhorn, Katelyn N Cutts, Brooke Harrow, et al.
Future Oncology (London, England)|August 18, 2023
The MOTION study: a randomized, phase III study of vimseltinib for the treatment of tenosynovial giant cell tumorWilliam D Tap, Maitreyi G Sharma, Marc Vallee, et al.
Genes, Chromosomes & Cancer|July 16, 2015
Fusion events lead to truncation of FOS in epithelioid hemangioma of boneDavid G P van IJzendoorn, Danielle de Jong, Cleofe Romagosa, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Anticancer Research|September 4, 2020
Clinical Outcome of Surgically Treated Leiomyosarcoma of the Extremities: A Retrospective OverviewAnnelies VAN Beeck, Michiel VAN DE Sande, Veroniek VAN Praag, et al.
Journal of Clinical Pharmacology|October 12, 2020
Population Pharmacokinetic Analysis of Pexidartinib in Healthy Subjects and Patients With Tenosynovial Giant Cell Tumor or Other Solid TumorsOphelia Yin, Andrew J Wagner, Jia Kang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 15, 2018
Time dependent dynamics of wound complications after preoperative radiotherapy in Extremity Soft Tissue SarcomasJules Lansu, Jan Groenewegen, Frits van Coevorden, et al.
Sarcoma|December 9, 2014
Can orthopedic oncologists predict functional outcome in patients with sarcoma after limb salvage surgery in the lower limb? A nationwide studySjoerd Kolk, Kevin Cox, Vivian Weerdesteyn, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 18, 2021
Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centresMaria Anna Smolle, Michiel van de Sande, Andrew Hayes, et al.
Journal of Surgical Oncology|February 1, 2020
Incidence, treatment and outcome of abdominal metastases in extremity soft tissue sarcoma: Results from a multi-centre studyMaria A Smolle, Angelika Schaffler, Andreas Leithner, et al.
Clinical Sarcoma Research|December 9, 2020
Seeking international consensus on approaches to primary tumour treatment in Ewing sarcomaCraig Gerrand, Jessica Bate, Beatrice Seddon, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 1, 2026
Mixed-Methods to Define Meaningful Change using Exit Interviewand Clinical Trial Data in Patients with Tenosynovial Giant Cell Tumor (TGCT)Heather L Gelhorn, Katelyn N Cutts, Brooke Harrow, et al.
Future Oncology (London, England)|August 18, 2023
The MOTION study: a randomized, phase III study of vimseltinib for the treatment of tenosynovial giant cell tumorWilliam D Tap, Maitreyi G Sharma, Marc Vallee, et al.
Genes, Chromosomes & Cancer|July 16, 2015
Fusion events lead to truncation of FOS in epithelioid hemangioma of boneDavid G P van IJzendoorn, Danielle de Jong, Cleofe Romagosa, et al.
Pageof 4